GeneDx shares plunge 49% after Q1 earnings miss and lowered 2026 guidance.
GeneDx Holdings Corp. shares fell 49% on May 5, 2026, after the company reported a significant Q1 2026 earnings miss, a tenfold increase in net loss, and cut its full-year 2026 revenue guidance by 12%. The company cited a shift in product mix toward ...
